Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
100%
COVID-19
58%
Breakthrough Infection
57%
Neutralization
55%
Vaccination
49%
Neutralizing Antibody
47%
Omicron Coronavirus Variant
43%
Immunosuppression
19%
Adoptive Immunity
14%
ID50
11%
Epitope
6%
Medicine and Dentistry
Patient
55%
T-Cell Response
47%
Severe Acute Respiratory Syndrome Coronavirus 2
23%
Single Drug Dose
21%
Allogeneic Stem Cell Transplantation
19%
Cancer Cell
19%
Chronic Myelogenous Leukemia
19%
Cohort Analysis
19%
Immunosuppressive Treatment
19%
mRNA Vaccine
19%
Patient with Cancer
19%
COVID-19 Vaccine
19%
Hematologic Malignancy
18%
Biological Product
11%
Psoriasis
11%
Patient Recruitment
9%
Cells
7%
Cancer Therapy
6%
Cellular Immunity
6%